Terms: = Skin cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
153 results:
1. Salvianolic Acid B Significantly Suppresses the Migration of Melanoma Cells via Direct Interaction with β-Actin.
Zhang Y; Zhai W; Fan M; Wu J; Wang C
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398656
[TBL] [Abstract] [Full Text] [Related]
2. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.
Wu M; Hanly A; Gibson F; Fisher R; Rogers S; Park K; Zuger A; Kuang K; Kalin JH; Nocco S; Cole M; Xiao A; Agus F; Labadorf A; Beck S; Collard M; Cole PA; Alani RM
J Clin Invest; 2024 Feb; 134(6):. PubMed ID: 38300709
[TBL] [Abstract] [Full Text] [Related]
3. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
4. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
Pozniak J; Pedri D; Landeloos E; Van Herck Y; Antoranz A; Vanwynsberghe L; Nowosad A; Roda N; Makhzami S; Bervoets G; Maciel LF; Pulido-Vicuña CA; Pollaris L; Seurinck R; Zhao F; Flem-Karlsen K; Damsky W; Chen L; Karagianni D; Cinque S; Kint S; Vandereyken K; Rombaut B; Voet T; Vernaillen F; Annaert W; Lambrechts D; Boecxstaens V; Saeys Y; van den Oord J; Bosisio F; Karras P; Shain AH; Bosenberg M; Leucci E; Paschen A; Rambow F; Bechter O; Marine JC
Cell; 2024 Jan; 187(1):166-183.e25. PubMed ID: 38181739
[TBL] [Abstract] [Full Text] [Related]
5. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
[TBL] [Abstract] [Full Text] [Related]
6. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors.
Kovacs D; Flori E; Bastonini E; Mosca S; Migliano E; Cota C; Zaccarini M; Briganti S; Cardinali G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139209
[TBL] [Abstract] [Full Text] [Related]
7. Paris polyphylla saponins II inhibits invasive, migration and epithelial-mesenchymal transition of melanoma cells through activation of autophagy.
Cheng H; Chu J; Yang Y; Li Y; Wang M; Wu H; Wang M; Su J; Li Q
Toxicon; 2024 Jan; 237():107558. PubMed ID: 38072315
[TBL] [Abstract] [Full Text] [Related]
8. Tracking the emt-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes.
Zhou Q; Wang J; Zhang Z; Wuethrich A; Lobb RJ; Trau M
Biosens Bioelectron; 2024 Jan; 244():115819. PubMed ID: 37952322
[TBL] [Abstract] [Full Text] [Related]
9. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/emt Axis.
Park SJ; Jung HJ
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.
Illmer J; Zauner R; Piñón Hofbauer J; Wimmer M; Gruner S; Ablinger M; Bischof J; Dorfer S; Hainzl S; Tober V; Bergson S; Sarig O; Samuelov L; Guttmann-Gruber C; Shalom-Feuerstein R; Sprecher E; Koller U; Laimer M; Bauer JW; Wally V
Br J Dermatol; 2023 Dec; 190(1):80-93. PubMed ID: 37681509
[TBL] [Abstract] [Full Text] [Related]
11. OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1.
Gao Y; Tang J; Ma X; Zhang C; Huang L; Che J; Wen Y; Zhang Y; Zhu Y; Liu T; Zhang H
J Cell Physiol; 2023 Nov; 238(11):2546-2555. PubMed ID: 37642406
[TBL] [Abstract] [Full Text] [Related]
12. miR-224-5p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway.
Liu Y; Ruan H; Lu F; Peng H; Luan W
Pathol Res Pract; 2023 Sep; 249():154772. PubMed ID: 37611431
[TBL] [Abstract] [Full Text] [Related]
13.
Romano B; Maresca DC; Somma F; Ahmadi P; Putra MY; Rahmawati SI; Chianese G; Formisano C; Ianaro A; Ercolano G
Mar Drugs; 2023 Jun; 21(7):. PubMed ID: 37504902
[TBL] [Abstract] [Full Text] [Related]
14. Localization of reference points in electromagnetic tracking data and their application for treatment error detection in interstitial breast brachytherapy.
Dürrbeck C; Schuster S; Sauer BC; Abu-Hossin N; Strnad V; Fietkau R; Bert C
Med Phys; 2023 Sep; 50(9):5772-5783. PubMed ID: 37458615
[TBL] [Abstract] [Full Text] [Related]
15. A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.
Gureghian V; Herbst H; Kozar I; Mihajlovic K; Malod-Dognin N; Ceddia G; Angeli C; Margue C; Randic T; Philippidou D; Nomigni MT; Hemedan A; Tranchevent LC; Longworth J; Bauer M; Badkas A; Gaigneaux A; Muller A; Ostaszewski M; Tolle F; Pržulj N; Kreis S
Cancer Gene Ther; 2023 Oct; 30(10):1330-1345. PubMed ID: 37420093
[TBL] [Abstract] [Full Text] [Related]
16. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, emt, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines.
Choudhari J; Nimma R; Nimal SK; Totakura Venkata SK; Kundu GC; Gacche RN
J Ethnopharmacol; 2023 Aug; 312():116472. PubMed ID: 37062530
[TBL] [Abstract] [Full Text] [Related]
17. Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.
Jaeger A; Gambheer SMM; Sun X; Chernyakov D; Skorobohatko O; Mack T; Kissel S; Pfeifer D; Zeiser R; Fisch P; Andrieux G; Bräuer-Hartmann D; Bauer M; Schulze S; Follo M; Boerries M; von Bubnoff N; Miething C; Hidalgo JV; Klein C; Weber T; Wickenhauser C; Binder M; Dierks C
Blood; 2023 Jun; 141(23):2824-2840. PubMed ID: 36696631
[TBL] [Abstract] [Full Text] [Related]
18. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
Zhou W; Xu X; Cen Y; Chen J
Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
[TBL] [Abstract] [Full Text] [Related]
19. Signatures of emt, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution.
Li X; Zhao S; Bian X; Zhang L; Lu L; Pei S; Dong L; Shi W; Huang L; Zhang X; Chen M; Chen X; Yin M
Theranostics; 2022; 12(17):7532-7549. PubMed ID: 36438481
[No Abstract] [Full Text] [Related]
20. Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype.
Chen X; Adhikary G; Ma E; Newland JJ; Naselsky W; Xu W; Eckert RL
Mol Carcinog; 2023 Feb; 62(2):236-248. PubMed ID: 36285644
[TBL] [Abstract] [Full Text] [Related]
[Next]
